dr. S.P.C. Lam

s.p.c.lam umcg.nl


  1. 2019
  2. Obokata, M., Reddy, Y. N. V., Shah, S. J., Kaye, D. M., Gustafsson, F., Hasenfuss, G., ... Borlaug, B. A. (2019). Effects of Interatrial Shunt on Pulmonary Vascular Function in Heart Failure With Preserved Ejection Fraction. Journal of the American College of Cardiology, 74(21), 2539-2550. https://doi.org/10.1016/j.jacc.2019.08.1062
  3. de Kleijn, D. P. V., Chong, S. Y., Wang, X., Yatim, S. M. J. M., Fairhurst, A-M., Vernooij, F., ... Wang, J-W. (2019). Toll-like receptor 7 deficiency promotes survival and reduces adverse left ventricular remodelling after myocardial infarction. Cardiovascular Research, 115(12), 1791-1803. https://doi.org/10.1093/cvr/cvz057
  4. PARAGON-HF Investigators, Chandra, A., Vaduganathan, M., Lewis, E. F., Claggett, B. L., Rizkala, A. R., ... Solomon, S. D. (2019). Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction The PARAGON-HF Trial. JACC. Heart failure, 7(10), 862-874. https://doi.org/10.1016/j.jchf.2019.05.015
  5. Ferreira, J. P., Kraus, S., Mitchell, S., Perel, P., Pineiro, D., Chioncel, O., ... Sliwa, K. (2019). World Heart Federation Roadmap for Heart Failure. Global heart, 14(3), 197-214. https://doi.org/10.1016/j.gheart.2019.07.004
  6. Tromp, J., Ferreira, J. P., Janwanishstaporn, S., Shah, M., Greenberg, B., Zannad, F., & Lam, C. S. P. (2019). Heart failure around the world. European Journal of Heart Failure. https://doi.org/10.1002/ejhf.1585
  7. Tan, E. S. J., Tay, W. T., Teng, T-H. K., Sim, D., Leong, K. T. G., Yeo, P. S. D., ... Lam, C. S. P. (2019). Ethnic differences in atrial fibrillation in patients with heart failure from Asia-Pacific. Heart, 105(11), 842-847. https://doi.org/10.1136/heartjnl-2018-314077
  8. Tan, E. S. J., Tay, W. T., Teng, T-H. K., Richards, A. M., Doughty, R. N., & Lam, C. S. P. (2019). The diabetes-atrial fibrillation paradox. Heart, 105(11). https://doi.org/10.1136/heartjnl-2019-315018
  9. Butler, J., Lam, C. S. P., Anstrom, K. J., Ezekowitz, J., Hernandez, A. F., O'Connor, C. M., ... Armstrong, P. W. (2019). Rationale and Design of the VITALITY-HFpEF Trial. Circulation-Heart failure, 12(5), [005998]. https://doi.org/10.1161/CIRCHEARTFAILURE.119.005998
  10. Wolsk, E., Kaye, D., Komtebedde, J., Shah, S. J., Borlaug, B. A., Burkhoff, D., ... Gustafsson, F. (2019). Central and Peripheral Determinants of Exercise Capacity in Heart Failure Patients With Preserved Ejection Fraction. JACC. Heart failure, 7(4), 321-332. https://doi.org/10.1016/j.jchf.2019.01.006
  11. Savarese, G., Vedin, O., D'Amario, D., Uijl, A., Dahlstrom, U., Rosano, G., ... Lund, L. H. (2019). Prevalence and Prognostic Implications of Longitudinal Ejection Fraction Change in Heart Failure. JACC. Heart failure, 7(4), 306-317. https://doi.org/10.1016/j.jchf.2018.11.019
  12. 2018
  13. Tromp, J., MacDonald, M. R., Tay, W. T., Teng, T-H. K., Hung, C-L., Narasimhan, C., ... Lam, C. S. P. (2018). Heart Failure With Preserved Ejection Fraction in the Young. Circulation, 138(24), 2763-2773. https://doi.org/10.1161/CIRCULATIONAHA.118.034720
  14. METEOR Study Grp, Verbree-Willemsen, L., Zhang, Y-N., Gijsberts, C. M., Schoneveld, A. H., Wang, J-W., ... de Kleijn, D. P. V. (2018). LDL extracellular vesicle coagulation protein levels change after initiation of statin therapy. Findings from the METEOR trial. International Journal of Cardiology, 271, 247-253. https://doi.org/10.1016/j.ijcard.2018.05.098
Previous 1 2 Next

ID: 20705626